Mental Health Statistics 2026: Trends and Insights

You've probably sensed it already. In your own life, in the lives of people you love, at work, online. Mental health conditions aren't rare. They aren't niche. And they aren't getting better on their own.

More than 1 billion people worldwide are living with a mental health condition, according to a September 2025 report from the World Health Organization (WHO). In the United States, nearly 1 in 4 adults experienced a mental health condition in the past year. Yet almost half of them received no treatment at all.

The bottom line: The data confirms what many people already feel. Mental health conditions are widespread, the system meant to treat them is deeply strained, and millions of people are falling through the cracks. Understanding the numbers can put your own experience in context and point toward better decisions about care.

Mental Health at a Glance: 2024–2025 Data

How Many People Are Affected

The scale is staggering, and the numbers have held steady at historically high levels for four consecutive years.

According to the 2024 NSDUH (National Survey on Drug Use and Health), released by the Substance Abuse and Mental Health Services Administration (SAMHSA) in July 2025, 23.4% of U.S. adults (61.5 million people) experienced a mental health condition in the past year. That rate has been statistically unchanged since 2021. The slight increase in raw numbers reflects population growth, not a leveling off of the crisis.

Within that group, 14.6 million adults had a serious mental illness that substantially interfered with daily life.

Depression

About 21.4 million people experienced a major depressive episode in 2024, after peaking in 2022 and easing slightly since. Depression hits young adults hardest: among those ages 18–25, 15.9% had a major depressive episode, nearly twice the overall adult rate.

A separate Centers for Disease Control and Prevention (CDC) measure found that 21.4% of adults reported depression symptoms in 2022, up from 18.5% in 2019.

Anxiety

Anxiety disorders are even more common. An estimated 19.1% of U.S. adults had an anxiety disorder in the past year, and 31.1% will experience one in their lifetime. Among young adults ages 18–25, 14.5% had moderate-to-severe generalized anxiety symptoms in 2024.

These aren't only American problems. Globally, 359 million people live with anxiety disorders, and just 1 in 4 receives any treatment.

Post-Traumatic Stress Disorder and Substance Use

Post-traumatic stress disorder (PTSD) affects 3.9% of the world's population over a lifetime, per the WHO, with rates substantially higher among people exposed to conflict.

Substance use disorders add another layer. In 2024, 48.4 million people aged 12 and older had a past-year substance use disorder. Among adults with a mental health condition, 34.5% also had a substance use disorder in 2024. For those with serious mental illness, the overlap reached 47.3%.

Suicidal Ideation

Suicidal ideation remains alarmingly high. About 14.3 million U.S. adults had serious thoughts of suicide in 2024. Among young adults ages 18–25, the rate was 12.6%, more than 1 in 8. In 2023, 49,316 people died by suicide in the United States.

Who's Hit Hardest

Mental health conditions don't affect everyone equally. Age, gender, race, income, and sexual orientation all shape who gets sick, who gets diagnosed, and who gets help.

Age

Young adults ages 18–25 have the highest rates of mental health conditions (33.2%) and serious mental illness (9.4%) among adult age groups. These are people navigating first jobs, new relationships, and financial independence while carrying a mental health burden that outpaces every other adult demographic.

Youth and Adolescents

The 2024 NSDUH brought a rare piece of encouraging news: the percentage of youth ages 12–17 who had a major depressive episode dropped to 15.4% from 20.8% in 2021. Serious suicidal thoughts among youth also declined, from 12.9% to 10.1% over the same period. These are the first significant improvements in over a decade.

The broader picture, though, remains concerning. Survey data show that nearly 1 in 3 adolescents ages 12–17 had a mental, emotional, or behavioral condition in 2022–2023, and among those who needed treatment, 61% had difficulty getting it, a 35% increase since 2018.

Major depressive episode rates still more than double between ages 12–13 (13.0%) and 16–17 (26.8%), and 20% of adolescents reported unmet mental health care needs. Half of all mental health conditions show symptoms by age 14. Loneliness compounds these risks: a global report in 2025 identified teenagers as the loneliest age group worldwide, and the WHO now links social disconnection to an estimated 871,000 deaths annually.

Gender

Women are diagnosed with depression at 1.66× the rate of men. Among adolescents, the gap widens sharply: nearly 1 in 3 teenage girls experiences a major depressive episode, compared to about 1 in 9 boys. Women are also nearly 3× more likely than men to have PTSD.

LGBTQ+ Youth

LGBTQ+ youth face dramatically elevated risks, and the numbers reflect what many of these young people already know from daily life. In 2024, 66% of LGBTQ+ youth reported recent symptoms of anxiety, and CDC data shows 22% of LGBQ+ high school students attempted suicide in the past year. These rates underscore how much environment and acceptance shape mental health outcomes.

Race and Ethnicity

Multiracial Americans report the highest rates of mental health conditions (35.2%), while American Indian/Alaska Native populations have the highest rate of serious mental illness of any racial or ethnic group.

The access gap is even more striking than the prevalence gap. 58% of White adults with mental health conditions receive services, compared to 39% of Black adults and 33% of Asian adults. The Kaiser Family Foundation (KFF) reports that data are not available for Native Hawaiian/Pacific Islander adults.

Income

Income may be the strongest predictor of all. A 2025 CDC analysis found that depression is roughly 3× higher among the lowest-income Americans compared to those at the highest income level. People with fewer financial resources face both greater exposure to stressors and fewer options for care.

The Treatment Gap

If you've struggled to find a therapist, get an appointment, or afford care, you aren't imagining the problem. The system has a structural gap, and millions of people are caught in it.

Of the 61.5 million adults with a mental health condition in 2024, 29.5 million did not receive mental health treatment. For substance use disorders, the gap is even wider: 80% of people who needed treatment didn't receive it. Among adults with both a mental health condition and a substance use disorder, only 14.5% received treatment for both conditions, and more than 41.2% received treatment for neither.

The top reasons people give for not getting treatment: cost, difficulty finding an available provider, and insurance barriers.

Provider Shortages

The provider shortage is real and worsening. As of December 2025, 40% of the U.S. population lives in a Mental Health Professional Shortage Area, and only 27.29% of need is being met in those regions. An American Psychological Association (APA) survey found that 46% of psychologists have no openings for new patients, and only 20% accept Medicaid.

By 2038, the U.S. is projected to face a shortage of 100,000 counselors, along with substantial shortages of psychiatrists.

For people already dealing with emotional exhaustion or worsening symptoms, these barriers make an already difficult situation feel impossible.

The Economic Cost

The consequences reach beyond any one person's experience. The WHO estimates that depression and anxiety alone cause $1 trillion in lost productivity and 12 billion lost working days globally each year. In the U.S., mental health conditions are the 5th leading cause of disability, and younger workers bear a disproportionate share: only 52% of Gen Z and 58% of millennials rate their mental wellbeing as good or very good, per Deloitte's 2025 survey.

How the Landscape Is Shifting

The crisis is large, but the response is evolving. Changes in care delivery, public conversation, and available treatments are reshaping the landscape in real time.

Telehealth

Online therapy has made care more accessible, but it hasn't closed the treatment gap. A 2025 analysis across 1.67 million Medicare beneficiaries found that virtual visits largely replace office visits rather than adding new ones. Telehealth works for many conditions, with comparable results to in-person care, but it can't solve a problem rooted in not having enough clinicians.

Stigma

Stigma is shifting in unexpected ways. An APA poll from 2025 found that young adults under 35 are less comfortable discussing mental health than older adults. Over half have withheld mental health information from a provider or friend, even as 52% said they'd be comfortable talking to an AI chatbot about their mental health. The generation most affected by mental health conditions is, paradoxically, the one most reluctant to talk about them in settings where it counts.

Workplace Mental Health

Work is where mental health symptoms often surface first, and the data reflects it. A 2025 report from Mind Share Partners found that employees whose companies support mental health are twice as likely to report no burnout or depression, yet 46% of workers said they would worry about losing their job if they discussed mental health at work.

The National Alliance on Mental Illness (NAMI) and Ipsos confirmed the disconnect in a 2026 workplace poll: 75% of employees say discussing mental health at work is appropriate, but only 57% feel comfortable doing so with their manager. Meanwhile, only half of the U.S. workforce knows how to access mental health benefits through their employer-sponsored insurance, even when coverage exists.

Emerging Treatments

For the roughly 35% of people with depression who don't respond adequately to two antidepressant trials, a diagnosis called treatment-resistant depression (TRD), the stakes are high. TRD affects an estimated 2.8+ million Americans in any given year, and people with TRD face a roughly 7-fold risk of attempting suicide compared to those with treatment-responsive depression.

Comorbid anxiety disorders and PTSD are also more common in TRD.

New options are gaining ground. In January 2025, the Food and Drug Administration (FDA) expanded the indication for esketamine (Spravato) as a standalone treatment for TRD, with clinical trials showing higher remission rates than placebo and noticeable relief within 24 hours. IV ketamine, though off-label for psychiatric use, has also shown strong results in peer-reviewed studies and non-inferiority to electroconvulsive therapy (ECT) for nonpsychotic TRD.

A growing body of recent research suggests that pairing ketamine with structured psychotherapy may extend treatment benefits.

Research is also expanding beyond depression. A 2025 randomized controlled trial provided early support for ketamine in treatment-resistant PTSD, and psilocybin and ibogaine are drawing regulatory attention; Texas allocated $50 million to ibogaine research in 2025.

For the millions of people whose symptoms persist after evidence-based psychotherapy or multiple medication trials, these aren't fringe developments. They represent an expansion of what's available when first-line treatments haven't been enough.

How Innerwell Can Help

If the statistics in this article describe your experience, or the experience of someone you love, you don't have to figure out the system on your own. Innerwell brings therapy, psychiatry, and advanced treatments together under one clinical team so that your therapist, psychiatrist, and care plan all live in the same place.

For depression, anxiety, and trauma, Master's- and Doctoral-level therapists use evidence-based approaches matched to each person's situation: cognitive behavioral therapy (CBT) to identify and shift unhelpful thought patterns, EMDR to process traumatic experiences, and dialectical behavior therapy (DBT) to build skills for managing intense emotions.

When medication support is needed, therapists and psychiatrists collaborate directly on care plans rather than working in separate silos. That coordination matters, especially when standard approaches haven't provided enough relief.

For people with treatment-resistant depression or trauma that hasn't responded to traditional therapy, Innerwell also offers ketamine-assisted psychotherapy (KAP). KAP pairs low-dose ketamine's ability to promote new neural connections with structured therapeutic support, so progress goes deeper and lasts longer. Take the free screener to see what kind of support might help.

Frequently Asked Questions

How do I know if what I'm feeling warrants professional help?

A useful threshold: if symptoms like persistent sadness, anxiety, irritability, or difficulty concentrating last most days for two weeks or more and interfere with work, relationships, or daily tasks, a clinical evaluation can clarify what's going on. You don't need a crisis to benefit from support. Many people seek help when coping strategies that used to work stop working, or when patterns keep repeating despite their best efforts.

Does insurance cover mental health treatment?

Federal parity law requires most employer-sponsored and marketplace plans to cover mental health services at the same level as medical care. In practice, coverage varies. High deductibles, limited provider networks, and low reimbursement rates mean that many therapists don't accept insurance. Cost and insurance barriers rank consistently as the top reasons people go without treatment. When evaluating a provider, ask about specific insurance acceptance, sliding-scale options, and session costs upfront.

Can mental health conditions develop at any age?

Yes. Half of all mental health conditions show initial symptoms by age 14, and 75% emerge by age 24. But new conditions can also develop later in life, often triggered by major transitions like job loss, caregiving, grief, or chronic illness. Older adults are frequently underdiagnosed because symptoms like fatigue or withdrawal are attributed to aging rather than treatable conditions. No age group is immune, and no age is too late to start treatment.